PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
BMP-7 1,112 Target Target BMP-14 14 2 0.02 -0.92 0.14 0.71
CXCL7 76 Target Disease Inflammation 252,734 11 0.00 -0.92 0.14 0.58
CD31/PECAM1 7 Target Target EPHB2 385 1 0.02 -0.92 0.14 0.73
CD4 112,219 Target Target CRG-2 41 6 0.00 -0.92 0.15 0.60
CCL4 5,638 Target Target CCL8 197 28 0.03 -0.92 0.14 0.71
CCL19 658 Target Disease Infection 766,637 97 0.00 -0.92 0.15 0.57
BAFFR 44 Target Target BLyS 457 6 0.04 -0.92 0.14 0.77
BMP-6 386 Target Target Collagen 138,882 57 0.01 -0.92 0.15 0.62
Apo-SAA 27 Target Disease Inflammation 252,734 4 0.00 -0.92 0.15 0.58
Exodus-2 27 Target Disease Inflammation 252,734 4 0.00 -0.92 0.15 0.58
DAPK2 27 Target Disease Breast Cancer 173,695 4 0.00 -0.92 0.15 0.59
CD4 112,219 Target Target Exodus-2 27 4 0.00 -0.92 0.15 0.60
CCL14 34 Target Target CCL2 3,560 5 0.01 -0.92 0.15 0.69
CRG-2 41 Target Target CXCL10 2,386 6 0.02 -0.92 0.15 0.71
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
Angiotensin Converting Enzyme 31,674 Target Drug Doxazosin Mesylate 47 7 0.01 -0.92 0.15 0.63
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
Cyclooxygenase-3 20 Target Disease Pain 409,851 3 0.00 -0.92 0.15 0.57
Cyclooxygenase-3 20 Target Disease Inflammation 252,734 3 0.00 -0.92 0.15 0.58
Angiotensin Converting Enzyme 31,674 Target Drug Apresoline (Hydralazine)- FDA 20 3 0.00 -0.92 0.15 0.62
BD2 76 Target Target BD4 26 3 0.07 -0.92 0.12 0.82
Hiv-1 Integrase 1,199 Target Disease Infection 766,637 180 0.01 -0.92 0.15 0.58
Proteinase-Activated Receptor 1 133 Target Disease Inflammation 252,734 20 0.00 -0.92 0.15 0.59
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
CD4 112,219 Target Target CD14 9,941 1,398 0.04 -0.92 0.14 0.68
CAPG 85 Target Drug Kabiramide C 7 1 0.04 -0.92 0.14 0.79
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Breast Cancer 173,695 6 0.00 -0.92 0.15 0.59
CD4 112,219 Target Disease Transplant Bone Marrow 26 4 0.00 -0.92 0.15 0.60
ERK1 18,374 Target Target ATF-2 Protein 13 2 0.00 -0.92 0.15 0.63
Adenosine A3 Receptor 164 Target Target Adenosine A1 Receptor 1,432 23 0.05 -0.92 0.14 0.76
Tissue-Type Plasminogen Activator 5,020 Target Drug Alteplase (Activase)- FDA 112 17 0.02 -0.92 0.15 0.71
Tissue-Type Plasminogen Activator 5,020 Target Drug Activase (Alteplase)- FDA 112 17 0.02 -0.92 0.15 0.71
APOH 110 Target Target APOE 12,771 17 0.01 -0.92 0.15 0.67
ApoE4 1,525 Target Disease Dementia 66,782 233 0.02 -0.92 0.15 0.66
CCL19 658 Target Target CD4 112,219 102 0.01 -0.92 0.16 0.63
CD4 112,219 Target Target CCL21 808 126 0.01 -0.92 0.16 0.63
CCL3 1,427 Target Target CXCL3 145 21 0.05 -0.92 0.14 0.76
CD4 112,219 Target Target CXCL9 1,016 159 0.01 -0.92 0.16 0.64
ALK Phos 19 Target Disease Cholesterol 182,390 3 0.00 -0.92 0.16 0.58
Complement Decay-Accelerating Factor 19 Target Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
CD4 112,219 Target Target Tegument Protein Vp16 19 3 0.00 -0.92 0.16 0.60
CCL4 5,638 Target Target CCL1 220 34 0.03 -0.92 0.15 0.72
CNTF 1,613 Target Disease Leukemia 162,805 256 0.02 -0.92 0.16 0.63
CD4 112,219 Target Drug Acyclovir (Zovirax)- FDA 50 8 0.00 -0.92 0.16 0.60
Macrophage Metalloelastase 100 Target Target Elastase 13,875 16 0.01 -0.92 0.16 0.67
CCL5 2,002 Target Target CXCL3 145 22 0.04 -0.92 0.15 0.75
Acetyl-Coa Carboxylase 1 118 Target Disease Cholesterol 182,390 19 0.00 -0.92 0.16 0.60
Vascular Cell Adhesion Protein 1 31 Target Disease Cholesterol 182,390 5 0.00 -0.92 0.16 0.59
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
APOH 110 Target Disease Cholesterol 182,390 18 0.00 -0.91 0.16 0.60
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
Endotoxin receptor 115 Target Disease Inflammation 252,734 19 0.00 -0.91 0.17 0.59
Retinoic Acid Receptor Gamma-1 6 Target Disease Cancer 1,053,491 1 0.00 -0.91 0.17 0.55
Retinoic Acid Receptor Gamma-1 6 Target Disease Infection 766,637 1 0.00 -0.91 0.17 0.55
Retinoic Acid Receptor Gamma-1 6 Target Disease Carcinoma 433,099 1 0.00 -0.91 0.17 0.56
CTAP-3 6 Target Disease Inflammation 252,734 1 0.00 -0.91 0.17 0.57
Microsomal Glutathione S-Transferase 2 6 Target Disease Leukemia 162,805 1 0.00 -0.91 0.17 0.58
CTAP-3 6 Target Target Collagen 138,882 1 0.00 -0.91 0.17 0.58
5-Hydroxytryptamine 2b Receptor 18 Target Target Collagen 138,882 3 0.00 -0.91 0.17 0.59
Cysteinyl Leukotriene Receptor 2 24 Target Disease Asthma 109,610 4 0.00 -0.91 0.17 0.60
CTAP-3 6 Target Disease Autism 20,962 1 0.00 -0.91 0.17 0.63
Alcohol Dehydrogenase 8,492 Target Target Microsomal Glutathione S-Transferase 2 6 1 0.00 -0.91 0.17 0.65
C5a 4,164 Target Disease Inflammation 252,734 685 0.02 -0.91 0.16 0.63
Histamine H4 Receptor 168 Target Disease Asthma 109,610 28 0.01 -0.91 0.17 0.62
CAMK2A 42 Target Target Calmodulin 25,240 7 0.01 -0.91 0.17 0.64
CD4 112,219 Target Target CD95 4,266 691 0.03 -0.91 0.16 0.66
BMP-2B 18 Target Target BMP-2 3,889 3 0.01 -0.91 0.17 0.68
Collagen 138,882 Target Target Complement Component C1q 167 28 0.01 -0.91 0.17 0.61
N-Type Calcium Channel 453 Target Disease Pain 409,851 76 0.01 -0.91 0.17 0.59
Artemin 184 Target Disease Pain 409,851 31 0.00 -0.91 0.17 0.58
CCL5 2,002 Target Target CCL1 220 34 0.05 -0.91 0.15 0.76
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
CCL19 658 Target Disease Inflammation 252,734 112 0.01 -0.91 0.17 0.61
CKMM 55 Target Target CKBB 57 5 0.09 -0.91 0.09 0.86
Adiponectin 11,994 Target Disease Cholesterol 182,390 1,944 0.04 -0.91 0.16 0.67
D4-GDI 35 Target Disease Leukemia 162,805 6 0.00 -0.91 0.17 0.59
CNTF 1,613 Target Target Cardiotrophin-1 351 51 0.07 -0.91 0.15 0.78
EPHA4 357 Target Target EPHA3 140 18 0.08 -0.91 0.13 0.82
CXCL7 76 Target Target CXCL3 145 9 0.09 -0.91 0.12 0.84
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
CCL7 274 Target Disease Infection 766,637 48 0.00 -0.91 0.18 0.57
Adiponectin 11,994 Target Disease Inflammation 252,734 2,026 0.04 -0.91 0.17 0.65
CCL18 256 Target Disease Inflammation 252,734 45 0.01 -0.91 0.18 0.60
Glucocorticoid Receptor 10,306 Target Target Vitamin D Receptor Interacting Protein 17 3 0.01 -0.91 0.18 0.66
Erbb2 4,536 Target Target beta-Cellulin 17 3 0.01 -0.91 0.18 0.68
CD4 112,219 Target Target CD72 198 35 0.01 -0.91 0.18 0.62
FABP3 134 Target Target FABP1 90 10 0.09 -0.91 0.11 0.84
CCL14 34 Target Target CXCL10 2,386 6 0.02 -0.91 0.18 0.71
ERBB3 1,154 Target Target beta-Cellulin 17 3 0.02 -0.91 0.18 0.72
CCL5 2,002 Target Target CCL14 34 6 0.02 -0.91 0.18 0.72
ERBB4 994 Target Target beta-Cellulin 17 3 0.02 -0.91 0.18 0.73
Glutathione Peroxidase 2 67 Target Disease Inflammation 252,734 12 0.00 -0.91 0.18 0.59
CD68 6,424 Target Disease Inflammation 252,734 1,130 0.03 -0.91 0.18 0.64
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Brain Tumors 16,749 7 0.01 -0.91 0.18 0.65
Multidrug Resistance-Associated Protein 2 462 Target Disease Breast Cancer 173,695 84 0.01 -0.90 0.18 0.62
EPHB4 329 Target Target EPHB2 385 34 0.10 -0.90 0.10 0.84
Mu Opioid Receptor 4,576 Target Disease Pain 409,851 835 0.02 -0.90 0.18 0.62
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78